Does NADROPARIN Cause Agranulocytosis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Agranulocytosis have been filed in association with NADROPARIN. This represents 1.2% of all adverse event reports for NADROPARIN.
8
Reports of Agranulocytosis with NADROPARIN
1.2%
of all NADROPARIN reports
0
Deaths
8
Hospitalizations
How Dangerous Is Agranulocytosis From NADROPARIN?
Of the 8 reports, 8 (100.0%) required hospitalization, and 4 (50.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does NADROPARIN Cause?
Foetal exposure during pregnancy (81)
Off label use (77)
Premature baby (73)
Maternal exposure during pregnancy (72)
Drug ineffective (54)
Sepsis (46)
Dyspnoea (44)
Fall (43)
Exposure during pregnancy (42)
Confusional state (40)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which NADROPARIN Alternatives Have Lower Agranulocytosis Risk?
NADROPARIN vs NAFARELIN
NADROPARIN vs NAFCILLIN
NADROPARIN vs NAFCILLIN\NAFCILLIN
NADROPARIN vs NAFRONYL
NADROPARIN vs NAFTIFINE